Biodesix, Inc. (BDSX) financial statements (2022 and earlier)

Company profile

Business Address 2970 WILDERNESS PLACE
BOULDER, CO 80301
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments32,71262,126
Cash and cash equivalents32,71262,126
Receivables3,65615,304
Other current assets7,2458,710
Total current assets:43,61386,140
Noncurrent Assets
Property, plant and equipment4,1793,178
Intangible assets, net (including goodwill)26,64828,291
Goodwill15,03115,031
Intangible assets, net (excluding goodwill)11,61713,260
Other noncurrent assets1,6573,461
Total noncurrent assets:32,48434,930
TOTAL ASSETS:76,097121,070
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,32716,753
Accounts payable1,6628,964
Accrued liabilities7,6657,789
Deferred revenue1,8503,532
Debt1911,840
Business combination, contingent consideration, liability17,764 
Total current liabilities:28,96032,125
Noncurrent Liabilities
Long-term debt and lease obligation9,99315,926
Long-term debt, excluding current maturities9,99315,926
Liabilities, other than long-term debt17,41731,853
Other liabilities1,3891,921
Business combination, contingent consideration, liability16,02829,932
Total noncurrent liabilities:27,41047,779
Total liabilities:56,37079,904
Stockholders' equity
Stockholders' equity attributable to parent19,72741,166
Common stock3127
Additional paid in capital321,669299,953
Accumulated deficit(301,973)(258,814)
Total stockholders' equity:19,72741,166
TOTAL LIABILITIES AND EQUITY:76,097121,070

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Revenues54,50645,557
Gross profit:54,50645,557
Operating expenses(95,446)(68,491)
Operating loss:(40,940)(22,934)
Nonoperating expense
(Other Nonoperating expense)
(2,219)(8,416)
Interest and debt expense(2,210)(7,604)
Loss before gain (loss) on sale of properties:(45,369)(38,954)
Other undisclosed net income2,2107,604
Net loss available to common stockholders, diluted:(43,159)(31,350)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(43,159)(31,350)
Comprehensive loss, net of tax, attributable to parent:(43,159)(31,350)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: